NewLimit
Extending human healthspan with therapeutics that address aging at its cellular source
NewLimit aims to extend the human healthspan with therapeutics that address aging at its cellular source. We are merging AI and genomics to produce reprogramming medicines that make old human cells function like young ones, giving everyone longer, healthier lives.
Testimonial
Related Companies
Liminal
Unlimited, secure, multi-model AI for enterprises
Denver, Colorado, United States
Endolith
AI-powered microbes unlocking the world’s next wave of copper and critical minerals
Denver, Colorado, United States
Doctours
100M Americans are forced to pick between forgoing care & medical debt. Doctours offers a third option: Medical Tourism.
San Francisco, California, United States
FeltSense
AI Agents as Fully Autonomous Founders (Stealth)
New York, NY & San Francisco, CA
GenProof
GenProof generates mathematical proofs that guarantee 100% code correctness
San Francisco, California, United States
Klona Biotech
The future of human tissue replacements using 3D printing
London, United Kingdom
Glīd
Autonomous dual-mode vehicles that seamlessly transition between road and rail to deliver faster, greener, and more resilient first-mile logistics
Shaver Lake, CA
